Need to put some production capacity into Sawston to perform a trial on Direct. I'm guessing the third party investor (co)developed and/or produces the automated production system for Direct. With all the conjecture or moreover manipulation in regards to method B in phase I now with method B exclusively used in all phase II trials perhaps NW could provide further enlightenment into method B origins in phase II PR. Ready had some sage analysis a couple weekends ago and I completely agree a CI partnership brings further validation to Direct's data to date. The third trial covering the same ground as phase I is likely the one to be partnered and be done in other countries. Cueing off Ready's rather positive outlook on L I'll think NW may end up with two CI partners BMY in the States and Astra in UK. But only after phase I final analysis is complete.
News 
Market Data 
Discover 
